Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
View ORCID ProfileAriel Israel, Yotam Shenhar, Ilan Green, View ORCID ProfileEugene Merzon, Avivit Golan-Cohen, View ORCID ProfileAlejandro A Schäffer, View ORCID ProfileEytan Ruppin, View ORCID ProfileShlomo Vinker, View ORCID ProfileEli Magen
doi: https://doi.org/10.1101/2021.08.19.21262111
Ariel Israel
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
MD, PhDYotam Shenhar
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
MDIlan Green
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
2Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
MDEugene Merzon
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
2Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
MDAvivit Golan-Cohen
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
2Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
MDAlejandro A Schäffer
3Cancer Data Science Laboratory, National Cancer Institute, Bethesda, MD USA
PhDEytan Ruppin
3Cancer Data Science Laboratory, National Cancer Institute, Bethesda, MD USA
MD, PhDShlomo Vinker
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
2Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
MD, MHAEli Magen
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
4Medicine C Department, Clinical Immunology and Allergy Division, Barzilai University Medical Center, Ben Gurion University of the Negev, Israel
MDArticle usage
Posted August 22, 2021.
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
Ariel Israel, Yotam Shenhar, Ilan Green, Eugene Merzon, Avivit Golan-Cohen, Alejandro A Schäffer, Eytan Ruppin, Shlomo Vinker, Eli Magen
medRxiv 2021.08.19.21262111; doi: https://doi.org/10.1101/2021.08.19.21262111
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
Ariel Israel, Yotam Shenhar, Ilan Green, Eugene Merzon, Avivit Golan-Cohen, Alejandro A Schäffer, Eytan Ruppin, Shlomo Vinker, Eli Magen
medRxiv 2021.08.19.21262111; doi: https://doi.org/10.1101/2021.08.19.21262111
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (625)
- Anesthesia (162)
- Cardiovascular Medicine (2341)
- Dermatology (205)
- Emergency Medicine (376)
- Epidemiology (11713)
- Forensic Medicine (10)
- Gastroenterology (695)
- Genetic and Genomic Medicine (3697)
- Geriatric Medicine (347)
- Health Economics (632)
- Health Informatics (2377)
- Health Policy (928)
- Hematology (340)
- HIV/AIDS (773)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3458)
- Nursing (195)
- Nutrition (520)
- Oncology (1805)
- Ophthalmology (534)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (231)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (416)
- Public and Global Health (6096)
- Radiology and Imaging (1263)
- Respiratory Medicine (822)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (397)
- Toxicology (50)
- Transplantation (171)
- Urology (145)